The clinical application value of gonadotropin-releasing hormone antagonist combined with low-dose HCG regimen in patients with ovarian hyper-stimulation based on clinical characteristics and laboratory indicators
CONCLUSION: GnRH-A combined with low-dose HCG regimen is feasible for patients with ovarian hyper-response during IVF-ET/ICSI, and does not affect the implantation rate, clinical pregnancy rate, live birth rate, and early abortion rate of such patients. Combined detection of basal serum FSH, AMH, LH, E2 and P levels on HCG injection day can effectively predict the occurrence of ovarian hyper-response.PMID:37692927 | PMC:PMC10492074
Source: American Journal of Translational Research - Category: Research Authors: Jiyun Wei Ting Ban Demin Shi Fengming Mo Qingmiao Wei Lanjing Wei Chunfeng Qu Source Type: research
More News: Hormones | ICSI (Intracytoplasmic Sperm Injection) | Laboratory Medicine | Ovaries | Pregnancy | Research